People with asthma who started semaglutide had nearly 40 percent fewer asthma attacks than similar patients started on an older diabetes drug, according to research presented at the European Respiratory Society Congress in Barcelona. The same work found about 20 percent fewer flare-ups among people with chronic obstructive pulmonary disease.
The finding has not been peer-reviewed. It was presented as conference research, which is an important distinction for anyone reading the headline number and wondering whether to call their doctor.
